Investigational prostaglandin D2receptor antagonists for airway inflammation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Investigational prostaglandin D2receptor antagonists for airway inflammation
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 25, Issue 6, Pages 639-652
Publisher
Informa UK Limited
Online
2016-04-20
DOI
10.1080/13543784.2016.1175434
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Asthma phenotypes and endotypes
- (2016) Gwen S. Skloot CURRENT OPINION IN PULMONARY MEDICINE
- Effect of the potent and selective DP1 receptor antagonist, asapiprant (S-555739), in animal models of allergic rhinitis and allergic asthma
- (2015) Go Takahashi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A novel CRTH2 antagonist: Single- and multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ACT-453859 in healthy subjects
- (2015) Martine Géhin et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Synthesis of a high specific activity methyl sulfone tritium isotopologue of fevipiprant (NVP-QAW039)
- (2015) Van T. Luu et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- The prostaglandin D2 receptor CRTH2 regulates accumulation of group 2 innate lymphoid cells in the inflamed lung
- (2015) E D Tait Wojno et al. Mucosal Immunology
- Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment
- (2015) Ian P. Hall et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459
- (2014) R. Pettipher et al. ALLERGY
- Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics
- (2014) Z. Diamant et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Anti-inflammatory actions of Chemoattractant Receptor-homologous molecule expressed on Th2 by the antagonist MK-7246 in a novel rat model of Alternaria alternata elicited pulmonary inflammation
- (2014) Malgorzata A. Gil et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Prostaglandin D2and the role of the DP1, DP2and TP receptors in the control of airway reflex events
- (2014) Sarah A. Maher et al. EUROPEAN RESPIRATORY JOURNAL
- Safety and Efficacy Of ARRY-502, a Potent, Selective, Oral CRTh2 Antagonist, In Patients With Mild To Moderate Th2-Driven Asthma
- (2014) Sally E. Wenzel et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
- (2014) David Cook et al. NATURE REVIEWS DRUG DISCOVERY
- Expression of DP2 (CRTh2), a Prostaglandin D2 Receptor, in Human Mast Cells
- (2014) Tae Chul Moon et al. PLoS One
- The prostaglandin D2 receptor (PTGDR) gene in asthma and allergic diseases
- (2013) V. García-Solaesa et al. ALLERGOLOGIA ET IMMUNOPATHOLOGIA
- Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseases
- (2013) David A. Sandham et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Inhibition of antigen-induced airway inflammation and hyperresponsiveness in guinea pigs by a selective antagonist of “chemoattractant receptor homologous molecule expressed on Th2 cells” (CRTH2)
- (2013) Mamoru Tasaki et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Update on the status of DP2 receptor antagonists; from proof of concept through clinical failures to promising new drugs
- (2013) Peter Norman EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Prostaglandin D2 pathway upregulation: Relation to asthma severity, control, and TH2 inflammation
- (2013) Merritt L. Fajt et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis
- (2013) Norbert Krug et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Identification of 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic Acid (Setipiprant/ACT-129968), a Potent, Selective, and Orally Bioavailable Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTH2) Antagonist
- (2013) Heinz Fretz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacological characterization of the late phase reduction in lung functions and correlations with microvascular leakage and lung edema in allergen-challenged Brown Norway rats
- (2013) Peter J. Mauser et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- CRTH2 antagonists in the treatment of allergic responses involving TH2 cells, basophils, and eosinophils
- (2012) Robert G. Townley et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Biochemical and pharmacological characterization of AZD1981, an orally available selective DP2antagonist in clinical development for asthma
- (2012) JA Schmidt et al. BRITISH JOURNAL OF PHARMACOLOGY
- UGT2B17 Genetic Polymorphisms Dramatically Affect the Pharmacokinetics of MK-7246 in Healthy Subjects in a First-in-Human Study
- (2012) Y-H Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459
- (2012) D. Singh et al. EUROPEAN RESPIRATORY JOURNAL
- Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients
- (2012) William W. Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Update on the Development of Antagonists of Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTH2). From Lead Optimization to Clinical Proof-of-Concept in Asthma and Allergic Rhinitis
- (2012) Roy Pettipher et al. JOURNAL OF MEDICINAL CHEMISTRY
- CRTH2 Antagonist MK-7246: A Synthetic Evolution from Discovery through Development
- (2012) Carmela Molinaro et al. JOURNAL OF ORGANIC CHEMISTRY
- Substituted indole-1-acetic acids as potent and selective CRTh2 antagonists—discovery of AZD1981
- (2011) Tim Luker et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of novel and potent CRTH2 antagonists
- (2011) Shinji Ito et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Optimization of phenylacetic acid derivatives for CRTH2 and DP selective antagonism
- (2011) Yingcai Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma
- (2011) N. Barnes et al. CLINICAL AND EXPERIMENTAL ALLERGY
- New perspectives in pharmacological treatment of mild persistent asthma
- (2011) Paolo Montuschi et al. DRUG DISCOVERY TODAY
- Prostanoid DP receptor antagonists suppress symptomatic asthma-like manifestation by distinct actions from a glucocorticoid in rats
- (2011) Yosuke Hirano et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A novel DP2receptor antagonist (AM-461): a patent evaluation of WO2011085033
- (2011) Peter Norman EXPERT OPINION ON THERAPEUTIC PATENTS
- Immune modulation for treatment of allergic disease
- (2011) Tran-Hoai T. Nguyen et al. IMMUNOLOGICAL REVIEWS
- The Extracellular Signal-regulated Kinase Mitogen-activated Protein Kinase/Ribosomal S6 Protein Kinase 1 Cascade Phosphorylates cAMP Response Element-binding Protein to InduceMUC5BGene Expression via d-Prostanoid Receptor Signaling
- (2011) Yeon Ho Choi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pharmacodynamics, Pharmacokinetics, and Safety of AM211: A Novel and Potent Antagonist of the Prostaglandin D2Receptor Type 2
- (2011) G. Bain et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacology of AM211, a Potent and Selective Prostaglandin D2 Receptor Type 2 Antagonist That Is Active in Animal Models of Allergic Inflammation
- (2011) G. Bain et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Discovery of AMG 853, a CRTH2 and DP Dual Antagonist
- (2011) Jiwen Liu et al. ACS Medicinal Chemistry Letters
- Azaindoles as potent CRTH2 receptor antagonists
- (2010) Daniel Simard et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases
- (2010) Michel Gallant et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist
- (2010) F. G. Gervais et al. MOLECULAR PHARMACOLOGY
- CRTH2 and D-Type Prostanoid Receptor Antagonists as Novel Therapeutic Agents for Inflammatory Diseases
- (2010) Rufina Schuligoi et al. PHARMACOLOGY
- Prostanoid receptor antagonists: development strategies and therapeutic applications
- (2009) RL Jones et al. BRITISH JOURNAL OF PHARMACOLOGY
- Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis
- (2009) George Philip et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Novel Function of CRTH2 in Preventing Apoptosis of Human Th2 Cells through Activation of the Phosphatidylinositol 3-Kinase Pathway
- (2009) L. Xue et al. JOURNAL OF IMMUNOLOGY
- Exploring the Mechanism of Agonist Efficacy: A Relationship between Efficacy and Agonist Dissociation Rate at the Muscarinic M3 Receptor
- (2009) D. A. Sykes et al. MOLECULAR PHARMACOLOGY
- Prostaglandin D2 Receptors DP and CRTH2 in the Pathogenesis of Asthma
- (2008) Masafumi Arima et al. CURRENT MOLECULAR MEDICINE
- Role of Prostaglandin D2 and Its Receptors in the Pathophysiology of Asthma
- (2008) Tsuyoshi Oguma et al. ALLERGOLOGY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now